The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation

Autoimmunity Reviews

Volumn 9, Issue 6, 2010, Pages 459-464

  Szodoray, Peter ^a   Papp, Gabor ^b   Nakken, Britt ^c   Harangi, Mariann ^b   Zeher, Margit ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c Faculty of Medicine   (Norway)

Author keywords

Autoimmune diseases; Malignant diseases; Photopheresis; Transplantation

Indexed keywords

APOPTOSIS; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CUTANEOUS T CELL LYMPHOMA; ENTERITIS; EXTRACORPOREAL PHOTOCHEMOTHERAPY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NEOPLASM; NONHUMAN; PHOTOCHEMOTHERAPY; PUVA; REVIEW; SYSTEMIC SCLEROSIS; TRANSPLANTATION;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; GRAFT REJECTION; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNITY; INTERLEUKIN-10; METHOXSALEN; PHOTOPHERESIS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION;

EID: 77949918845     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.12.011     Document Type: Review

References (39)

1. Edelson R.L. Photopheresis: a new therapeutic concept. Yale J Biol Med 62 (1989) 565-577
2. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12 (2006) 7-12
3. Joshi P.C., and Pathak M.A. Production of singlet oxygen and superoxide radicals by psoralens and their biological significance. Biochem Biophys Res Commun 112 (1983) 638-646
4. Di Renzo M., Rubegni P., Sbano P., Cuccia A., Castagnini C., Pompella G., et al. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family. Arch Dermatol Res 295 (2003) 175-182
5. Bladon J., and Taylor P.C. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 43 (2006) 85-94
6. Craciun L.I., Stordeur P., Schandené L., Duvillier H., Bron D., Lambermont M., et al. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation 74 (2002) 995-1000
7. Vowels B.R., Cassin M., Boufal M.H., et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 98 (1992) 686-692
8. Salskov-Iversen M., Berger C.L., and Edelson R.L. Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading. J Immune Based Ther Vaccines 3 (2005) 4
9. Rao V., Saunes M., Jørstad S., and Moen T. In vitro experiments demonstrate that monocytes and dendritic cells are rendered apoptotic by extracorporeal photochemotherapy, but exhibit unaffected surviving and maturing capacity after 30 Gy gamma irradiation. Scand J Immunol 68 (2008) 645-651
10. Enk A.H. Dendritic cells in tolerance induction. Immunol Lett 99 (2005) 8-11
11. Ludewig B., Odermatt B., Landmann S., Hengartner H., and Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 188 (1998) 1493-1501
12. Biagi E., Di Biaso I., Leoni V., Gaipa G., Rossi V., Bugarin C., et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4 + CD25 +GITR + Foxp3 + CD62L + functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 84 (2007) 31-39
13. Bladon J., and Taylor P. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Ther Apher Dial 12 (2008) 311-318
14. Gorgun G., Miller K.B., and Foss F.M. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood. 100 (2002) 941-947
15. Di Renzo M., Sbano P., De Aloe G., Pasqui A.L., Rubegni P., Ghezzi A., et al. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 151 (2008) 407-413
16. Loser K., Apelt J., Voskort M., Mohaupt M., Balkow S., Schwarz T., et al. IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol 179 (2007) 365-371
17. Reynolds N.J., Franklin V., Gray J.C., Diffey B.L., and Farr P.M. Narrow-band ultraviolet B and broadband ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 357 (2001) 2012-2016
18. Mork N.J., Gaudernack G., and Braathen L.R. Effect of UVA and PUVA on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells. Photodermatology 4 (1987) 66-72
19. Pepino P., Berger C.L., Fuzesi L., Panza A., Pierson R.N., Gutierrez C., et al. Primate cardiac allo- and xenotransplantation: modulation of the immune response with photochemotherapy. Eur Surg Res 21 (1989) 105-113
20. Barr M.L., Baker C.J., Schenkel F.A., McLaughlin S.N., Stouch B.C., Starnes V.A., et al. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant 14 (2000) 162-166
21. Higman M.A., and Vogelsang G.B. Chronic graft versus host disease. Br J Haematol 125 (2004) 435-454
22. Dall'Amico R., and Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 6 (2002) 296-304
23. Foss F.M., DiVenuti G.M., Chin K., Sprague K., Grodman H., Klein A., et al. Prospective study of extracorporeal photopheresis in steroide-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 45 (2005) 1187-1193
24. Berger C.L., Xu A.L., Hanlon D., Lee C., Schechner J., Glusac E., et al. Induction of human tumor-loaded dendritic cells. Int J Cancer 91 (2001) 438-447
25. Zic J.A. The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatol Ther 16 (2003) 337-346
26. Trautinger F., Knobler R., Willemze R., Peris K., Stadler R., Laroche L., et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer 42 (2006) 1014-1030
27. Atkinson M.A., and Maclaren N.K. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331 (1994) 1428-1436
28. Ludvigsson J., Samuelsson U., Ernerudh J., Johansson C., Stenhammar L., and Berlin G. Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial. Arch Dis Child 85 (2001) 149-154
29. Jonson C.O., Pihl M., Nyholm C., Cilio C.M., Ludvigsson J., and Faresjö M. Regulatory T cell-associated activity in photopheresis-induced immune tolerance in recent onset type 1 diabetes children. Clin Exp Immunol 153 (2008) 174-181
30. Hemmer B., Archelos J.J., and Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3 (2002) 291-301
31. Cavaletti G., Perseghin P., Dassi M., Oggioni N., Sala F., Braga M., et al. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. J Biol Regul Homeost Agents 18 (2004) 9-17
32. Rostami A.M., Sater R.A., Bird S.J., et al. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis. Mult Scler 5 (1999) 198-203
33. Cavaletti G., Perseghin P., Dassi M., Cavarretta R., Frigo M., Caputo D., et al. Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy in refractory relapsing-remitting multiple sclerosis. Neurol Sci 27 (2006) 24-32
34. Akhavan A., and Rudikoff D. Atopic dermatitis: systemic immunosuppressive therapy. Semin Cutan Med Surg 27 (2008) 151-155
35. Sand M., Bechara F.G., Sand D., Radenhausen M., Tomi N.S., Altmeyer P., et al. Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis. Dermatology 215 (2007) 134-138
36. Bisaccia E., Palangio M., and Gonzalez J. Extracorporeal photochemotherapy for the treatment of refractory Crohn's disease. Transfus Apher Sci 37 (2007) 171-174
37. Bournia V.K., Vlachoyiannopoulos P.G., Selmi C., Moutsopoulos H.M., and Gershwin M.E. Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 36 (2009) 176-200
38. Knobler R.M., French L.E., Kim Y., Bisaccia E., Graninger W., Nahavandi H., et al. Systemic Sclerosis Study Group. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 54 (2006) 793-799
39. Hashikabe M., Ohtsuka T., and Yamazaki S. Quantitative echographic analysis of photochemotherapy on systemic sclerosis skin. Arch Dermatol Res 296 (2005) 522-527